Brief: Erytech Confirms Plans To Submit BLA For Eryaspase In Hypersensitive All Patients
July 21 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH CONFIRMS PLANS TO SUBMIT BLA FOR ERYASPASE IN
HYPERSENSITIVE ALL PATIENTS
* ERYTECH PHARMA SA - COMPANY EXPECTS TO SUBMIT BLA BEFORE
END OF
YEAR
Source text for Eikon: ID:nGNXcbBhYn
Further company coverage: ERYP.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure